163 related articles for article (PubMed ID: 9751109)
41. Scleroderma--developing measures of response.
Furst DE; Khanna D; Mattucci-Cerinic M; Silman AJ; Merkel PA; Foeldvari I;
J Rheumatol; 2005 Dec; 32(12):2477-80. PubMed ID: 16331791
[TBL] [Abstract][Full Text] [Related]
42. [Scleroderma in children].
Beaudoing A; Bost M; Pont J; Dieterlen M
Pediatrie; 1971; 26(5):529-46. PubMed ID: 5565710
[No Abstract] [Full Text] [Related]
43. Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma.
Humbert P; Aubin F; Dupond JL; Delaporte E
Arch Dermatol; 1995 Jul; 131(7):850-1. PubMed ID: 7611809
[No Abstract] [Full Text] [Related]
44. Natural remedies for scleroderma.
Gaby AR
Altern Med Rev; 2006 Sep; 11(3):188-95. PubMed ID: 17217320
[TBL] [Abstract][Full Text] [Related]
45. Coexistence of recurrent generalized morphea and systemic sclerosis.
Hayashi M; Ichiki Y; Kitajima Y
Acta Derm Venereol; 2009; 89(3):329-30. PubMed ID: 19479146
[No Abstract] [Full Text] [Related]
46. [Therapeutic effect of penicillin in scleroderma].
SELENYI A
Borgyogy Venerol Sz; 1956 Mar; 10(2):93. PubMed ID: 13315539
[No Abstract] [Full Text] [Related]
47. Avocado-Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited.
Salehi B; Rescigno A; Dettori T; Calina D; Docea AO; Singh L; Cebeci F; Özçelik B; Bhia M; Dowlati Beirami A; Sharifi-Rad J; Sharopov F; Cho WC; Martins N
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31940989
[TBL] [Abstract][Full Text] [Related]
48. Iloprost for scleroderma.
Constans T; Diot E; Lasfargues G
Ann Intern Med; 1991 Apr; 114(7):606. PubMed ID: 1705762
[No Abstract] [Full Text] [Related]
49. [Treatment of scleroderma].
Wüthrich B
Schweiz Rundsch Med Prax; 1973 Sep; 62(38):1149-55. PubMed ID: 4148265
[No Abstract] [Full Text] [Related]
50. [Effect of penicillin and D-penicillamine on beta-galactosidase activity in patients with progressive scleroderma].
Schulze E; Herrmann K; Haustein UF; Krusche U; Rothenburger I
Dermatol Monatsschr; 1988; 174(11):661-6. PubMed ID: 3145222
[No Abstract] [Full Text] [Related]
51. Systemic sclerosis and localized scleroderma in childhood.
Zulian F
Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
[TBL] [Abstract][Full Text] [Related]
52. [Treatment with hyaluronidase in dermatology].
Wozniak KD; Braun W
Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845
[No Abstract] [Full Text] [Related]
53. [Unsaponifiable fractions of the avocado and soy bean in gyneocology].
Trevoux R
J Gynecol Obstet Biol Reprod (Paris); 1977 Jan; 6(1):99-105. PubMed ID: 558245
[TBL] [Abstract][Full Text] [Related]
54. Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al.
Braun J; Sieper J; Riemekasten G; Hiepe F
Arthritis Rheum; 1999 Jan; 42(1):196-8. PubMed ID: 9920036
[No Abstract] [Full Text] [Related]
55. Oral administration of avocado soybean unsaponifiables (ASU) reduces ischemic damage in the rat hippocampus.
Yaman M; Eser O; Cosar M; Bas O; Sahin O; Mollaoglu H; Fidan H; Songur A
Arch Med Res; 2007 Jul; 38(5):489-94. PubMed ID: 17560453
[TBL] [Abstract][Full Text] [Related]
56. Other rheumatic diseases in adolescence. Dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis.
Hom C; Ilowite NT
Adolesc Med; 1998 Feb; 9(1):69-83, vi. PubMed ID: 10961253
[TBL] [Abstract][Full Text] [Related]
57. The use of pentoxifylline in the treatment of systemic sclerosis and lipodermatosclerosis: a unifying hypothesis?
Goldman MP
J Am Acad Dermatol; 1994 Jul; 31(1):135-6. PubMed ID: 8054069
[No Abstract] [Full Text] [Related]
58. Iloprost as cyclic five-day infusions in the treatment of scleroderma. An open pilot study in 20 patients treated for one year.
Biasi D; Carletto A; Caramaschi P; Zeminian S; Pacor ML; Corrocher R; Bambara LM
Rev Rhum Engl Ed; 1998 Dec; 65(12):745-50. PubMed ID: 9923042
[TBL] [Abstract][Full Text] [Related]
59. Salazopyrin in the treatment of scleroderma.
Stáva Z; Kobíková M
Br J Dermatol; 1977 May; 96(5):541-4. PubMed ID: 17429
[TBL] [Abstract][Full Text] [Related]
60. Scleroderma and sclerotic skin conditions: unapproved treatments.
Jablonska S; Blaszczyk M
Clin Dermatol; 2002; 20(6):634-7. PubMed ID: 12490356
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
